» Articles » PMID: 27055387

Interventional Oncology for Hepatocellular Carcinoma

Overview
Specialty Gastroenterology
Date 2016 Apr 9
PMID 27055387
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is increasing in incidence. The overall prognosis of patients with liver cancer is poor. The Barcelona Clinic Liver Cancer (BCLC) classification in 5 stages is endorsed by European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Disease (AASLD). This classification is recommended for treatment allocation. Because a small proportion of patients are suitable for curative surgical treatment, various locoregional therapies are widely used to manage patients with HCC. The image-guided therapies, also called interventional radiology or interventional oncology (IO) techniques consisted in percutaneous or endovascular approach. This article reviews the different IO treatments available in HCC patients and the strength of the data.

Citing Articles

X-ray Opaque Polymer Drug-Eluting Beads Loaded with Iodized Oil: Preparation and In Vitro and In Vivo Evaluations.

Zhang J, Yuan B, Zhang X, Zhang H, Wang H, Wang X ACS Omega. 2024; 9(29):31353-31358.

PMID: 39072120 PMC: 11270547. DOI: 10.1021/acsomega.3c09368.


A Novel Multi-Mode Thermal Therapy for Colorectal Cancer Liver Metastasis: A Pilot Study.

Li W, Lou Y, Wang G, Zhang K, Xu L, Liu P Biomedicines. 2022; 10(2).

PMID: 35203498 PMC: 8869583. DOI: 10.3390/biomedicines10020280.


S100 family members: potential therapeutic target in patients with hepatocellular carcinoma: A STROBE study.

Zhang C, Yao R, Chen J, Zou Q, Zeng L Medicine (Baltimore). 2021; 100(3):e24135.

PMID: 33546025 PMC: 7837992. DOI: 10.1097/MD.0000000000024135.


Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions.

Inchingolo R, Posa A, Mariappan M, Spiliopoulos S World J Gastroenterol. 2019; 25(32):4614-4628.

PMID: 31528090 PMC: 6718039. DOI: 10.3748/wjg.v25.i32.4614.


Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.

Katsanos K, Kitrou P, Spiliopoulos S, Maroulis I, Petsas T, Karnabatidis D PLoS One. 2017; 12(9):e0184597.

PMID: 28934265 PMC: 5608206. DOI: 10.1371/journal.pone.0184597.